Cribsy receives NIH Phase II funding to validate home-based developmental screening
Early Markers is pleased to share that the National Institutes of Health has awarded a Small Business Innovation Research Phase II grant of approximately $2 million over three years to validate Cribsy, our smartphone-based screener for neuromotor risk in infants. The award comes from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and runs through August 2029. The problem we are working on Early intervention changes outcomes for children with developmental delays, but it depends on early identification, and fewer than a third of children with developmental disabilities are identified before they enter school. Families in rural areas, on tribal lands, and in communities short of pediatric specialists wait longest. Cribsy is built to move the first screen into the home: parents record short videos of their infant on a phone, and AI models analyze the infant's movement to flag risk for a clinician to review. What Phase II will do A validat...
.png)
